Mereo BioPharma Files for Common Stock Offering by Holders
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)
Mereo BioPharma: Strong Cash Position Amid Clinical Progress
BTIG Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $6